Severe Combined Immunodeficiency in Fetus - A Life-Threatening Immunodeficiency

Introduction

SCID, also known as severe combined immunodeficiency, is an extremely uncommon genetic disorder that gives rise to life-threatening complications in the immune system. This condition falls under the category of primary immune deficiencies. In the United States, approximately one out of every 58,000 newborns are diagnosed with SCID annually.

What Is Severe Combined Immunodeficiency in the Fetus?

During the early stages of development, the immune system of a growing fetus originates in the bone marrow. Within the bone marrow, there exist stem cells that have the potential to differentiate into three distinct types of blood cells: red blood cells, white blood cells, and platelets.

White blood cells play a crucial role in safeguarding the body against infections and foreign invaders. Among the various types of white blood cells, lymphocytes, are of particular importance. Lymphocytes can be categorized into two main types: B-cells and T-cells. These cells play a pivotal role in combating infections. T-cells are responsible for identifying, attacking, and eliminating invading pathogens. B-cells produce antibodies that possess the ability to "remember" a previous infection, thereby enabling a swift response if the body is exposed to the same pathogen again.

SCID is classified as a "combined" immunodeficiency disorder since it affects both of these infection-fighting white blood cells. In a fetus with SCID, the body either has an insufficient number of lymphocytes or the lymphocytes fail to function properly. Due to the compromised immune system, the body faces challenges in effectively combating germs such as viruses, bacteria, and fungi, which are the causative agents of infections.

What Causes Severe Combined Immunodeficiency in the Fetus?

There are various types of severe combined immunodeficiency, with the most prevalent one being linked to a gene issue on the X chromosome that solely affects males. Females can carry the condition, but their immune systems can still combat infections due to inheriting a normal X chromosome. However, males with only one X chromosome will develop the disease if the gene is abnormal. Additionally, another form of SCID is caused by a lack of an enzyme necessary for lymphocyte development, while other genetic issues can cause different types of SCID.

In babies with SCID, a mistake in their genes leads to a missing or faulty protein that is crucial for the normal development and functioning of the immune system. Different genes can be affected, causing different types of SCID. The names of these types are based on the specific protein or gene that is affected. Some commonly encountered types include common gamma chain deficiency, adenosine deaminase (ADA) deficiency, JAK 3 kinase deficiency, MHC class II deficiency, and recombinase activating gene (RAG) deficiency. Even while all forms of SCID in babies are normally managed and treated similarly, pinpointing the precise etiology is crucial for two reasons: first, certain disorders may have targeted treatments, and second, proper genetic counseling may be offered for upcoming pregnancies.

What Are the Signs and Symptoms of Severe Combined Immunodeficiency in the Fetus?

SCID babies may appear healthy at birth and in the first few weeks of life due to antibodies passed from the mother. However, signs of SCID usually appear within the first three to six months, including frequent infections, severe thrush, poor feeding, chronic diarrhea, and skin rashes. Germs that are harmless to healthy individuals can be life-threatening to SCID babies, including Pneumocystis jiroveci pneumonia, Aspergillus, cytomegalovirus, and cryptosporidium. Common childhood infections like chickenpox and herpes simplex can also be dangerous for SCID babies.

How Is Severe Combined Immunodeficiency in the Fetus Diagnosed?

Parents may not realize their baby has SCID until they notice repeated infections, poor weight gain, or feeding problems. However, the first sign of trouble can be a serious infection that rapidly worsens the baby's condition, requiring immediate hospitalization, and sometimes even intensive care. Routine investigations may reveal a low lymphocyte count in the blood, which can lead to suspicion of SCID. Once SCID is suspected, the infant will be referred to a specialist immunology center for further investigation to confirm the diagnosis and determine the type of SCID.

The use of monoclonal antibodies to stain fetal blood samples acquired during fetoscopy has allowed for the diagnosis of severe combined immunodeficiency (SCID) during pregnancy. Previously, prenatal diagnosis of SCID was limited to situations when a recognized metabolic abnormality, such as adenosine deaminase deficiency, was present. Recent research suggests, however, that prenatal diagnosis may now be expanded to a broader range of high-risk pregnancies.

How Is Severe Combined Immunodeficiency Treated?

• SCID is a medical emergency that affects infants. Without prompt medical attention, infants diagnosed with SCID are unlikely to survive beyond their first year of life. The most common treatment for SCID is a stem cell transplant or a bone marrow transplant, which involves the infusion of stem cells from a donor to rebuild the child's immune system.

• The most effective stem cell transplants are those that use cells donated by a sibling, and in some cases, a parent's stem cells may also be a suitable match. However, if there are no compatible donors within the family, doctors may use stem cells from an unrelated donor.

• In certain cases, children with SCID may require chemotherapy before undergoing a transplant. Within the first few months of life, before they become infected, infants with SCID who undergo a stem cell transplant have a better chance of surviving.

• Clinical trials have demonstrated promising outcomes for gene therapy as a potential treatment for certain forms of SCID. However, due to the associated risks, its widespread implementation has not been realized thus far. Ongoing research continues to explore the potential of gene therapy in addressing SCID.

Conclusion

Having SCID can be really tough for babies and their families. They often have to go through a lot of procedures and stay in the hospital multiple times. It is a really stressful situation for everyone involved. SCID messes with the immune system, making babies more prone to dangerous infections and other complications.